Clinical Trials · NCT00667732
How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Oregon Health and Science University
- Enrollment
- 41
- Start date
- Mar 2007
- Locations
- 3 sites, United States
- Primary endpoint
- The Percentage of Intent to Treat Participants Randomized and Treated in Each Arm Who Had Lab-measured A1c <6.5% at 24 Weeks of Treatment